SCHEMBL6670542

SCHEMBL6670542

CCCc1cc(C=CC(=O)C(C)(C)P(=O)(O)O)cc(OC)c1O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 13/20 0.51
PTGS1 P23219 4/20 0.49
PTGS2 P35354 3/20 0.49
STAT3 P40763 3/20 0.47
PTGES O14684 2/20 0.47
NFKB1 P19838 2/20 0.47
NFKB2 Q00653 2/20 0.47
RELA Q04206 2/20 0.47
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2B6 P20813 1/20 0.46
PKM P14618 1/20 0.45
MET P08581 2/20 0.43
NFE2L2 Q16236 2/20 0.43
KMT2A Q03164 1/20 0.41
KDM4E B2RXH2 1/20 0.41
GAA P10253 1/20 0.41
APP P05067 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5666874 0.90 ALOX5 (0.50) ALOX5PTGS1PTGS2STAT3PTGES
SCHEMBL5666872 0.90 ALOX5 (0.50) ALOX5PTGS1PTGS2STAT3PTGES
SCHEMBL5665894 0.82 CYP1A2 (0.51) ALOX5PTGS1PTGS2STAT3PTGES
SCHEMBL5667592 0.79 ALDH1A1 (0.59) CYP1A2CYP2D6KMT2AKDM4EGAA
SCHEMBL5667595 0.79 ALDH1A1 (0.59) CYP1A2CYP2D6KMT2AKDM4EGAA
SCHEMBL5667477 0.78 TOP2A (0.45) ALOX5PTGS1PTGS2STAT3PTGES
SCHEMBL5667474 0.78 TOP2A (0.45) ALOX5PTGS1PTGS2STAT3PTGES
SCHEMBL5668058 0.75 CYP1A2 (0.59) ALOX5PTGS1PTGS2STAT3PTGES
SCHEMBL5668055 0.75 CYP1A2 (0.59) ALOX5PTGS1PTGS2STAT3PTGES
SCHEMBL5663406 0.73 ALOX5 (0.56) ALOX5PTGS1PTGS2STAT3PTGES

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004026242-A2 SUBSTITUTED KETOPHOSPHONATE INHIBITORS OF TUMOR CELL PROLIFERATION ILEX ONCOLOGY RESEARCH, SARL (CH) 2004-04-01 WO disclosed